carbostyril has been researched along with Minimal Disease, Residual in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marks, DI | 1 |
| Desideri, S; Fisher, J; Grossman, S; Lesser, G; Lustig, R; Mikkelsen, T; Wright, J; Ye, X | 1 |
1 review(s) available for carbostyril and Minimal Disease, Residual
| Article | Year |
|---|---|
The challenges of managing older patients with acute lymphoblastic leukemia.
Topics: Age Distribution; Aged; Antineoplastic Agents; Bacterial Infections; Female; Forecasting; Geriatric Assessment; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm, Residual; Patient Care Planning; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quinolones; Randomized Controlled Trials as Topic; Renal Insufficiency; Sex Distribution; Survival Analysis; Transplantation, Autologous; United Kingdom | 2015 |
1 trial(s) available for carbostyril and Minimal Disease, Residual
| Article | Year |
|---|---|
Phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing disease.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Neurosurgical Procedures; Quinolones; Radiotherapy | 2008 |